ProSeek Bio Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- (Upcoming)
- Investors
-
7
ProSeek Bio General Information
Description
Developer of multi-biomarker blood tests designed to improve diagnostics for women's health. The company utilizes glycoproteomics to detect multiple glycoform biomarkers in a single test, enabling medical professionals to achieve higher diagnostic accuracy and early detection for conditions such as ovarian cancer.
Contact Information
Website
www.proseek.bioCorporate Office
- Fairfield Road
- Brisbane, Queensland 4103
- Australia
Corporate Office
- Fairfield Road
- Brisbane, Queensland 4103
- Australia
ProSeek Bio Timeline
ProSeek Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | Upcoming | Clinical Trials - General | ||||
| 4. Accelerator/Incubator | 26-May-2026 | Completed | Clinical Trials - General | |||
| 3. Accelerator/Incubator | 28-Apr-2026 | Completed | Clinical Trials - General | |||
| 2. Seed Round | 13-Mar-2026 | $1.08M | $1.08M | Completed | Clinical Trials - General | |
| 1. Accelerator/Incubator | 06-Jun-2025 | Completed | Clinical Trials - General |
ProSeek Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed Preference |
ProSeek Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ProSeek Bio Patents
ProSeek Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024902607-A0 | Multi-biomarker assay system and method | Inactive | 21-Aug-2024 | ||
| WO-2026039870-A1 | Multi-biomarker assay system and method | Pending | 21-Aug-2024 | ||
| EP-4705771-A1 | Glycoprotein biomarkers for ovarian cancer diagnosis | Pending | 03-May-2023 | ||
| US-20260298932-A1 | Glycoprotein biomarkers for ovarian cancer diagnosis | Pending | 03-May-2023 | G01N33/57545 |
ProSeek Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ProSeek Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | |||
| UNSW Founders | Accelerator/Incubator | |||
| AngelLoop | Angel Group | Minority | ||
| AusHealth | Corporation | Minority | ||
| Edale Capital | Hedge Fund | Minority |
ProSeek Bio FAQs
-
When was ProSeek Bio founded?
ProSeek Bio was founded in 2023.
-
Where is ProSeek Bio headquartered?
ProSeek Bio is headquartered in Brisbane, Australia.
-
What is the size of ProSeek Bio?
ProSeek Bio has 10 total employees.
-
What industry is ProSeek Bio in?
ProSeek Bio’s primary industry is Diagnostic Equipment.
-
Is ProSeek Bio a private or public company?
ProSeek Bio is a Private company.
-
What is ProSeek Bio’s current revenue?
The current revenue for ProSeek Bio is .
-
How much funding has ProSeek Bio raised over time?
ProSeek Bio has raised $1.08M.
-
Who are ProSeek Bio’s investors?
MedTech Innovator, UNSW Founders, AngelLoop, AusHealth, and Edale Capital are 5 of 7 investors who have invested in ProSeek Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
